172 research outputs found

    A High Luminosity e+e- Collider to study the Higgs Boson

    Full text link
    A strong candidate for the Standard Model Scalar boson, H(126), has been discovered by the Large Hadron Collider (LHC) experiments. In order to study this fundamental particle with unprecedented precision, and to perform precision tests of the closure of the Standard Model, we investigate the possibilities offered by An e+e- storage ring collider. We use a design inspired by the B-factories, taking into account the performance achieved at LEP2, and imposing a synchrotron radiation power limit of 100 MW. At the most relevant centre-of-mass energy of 240 GeV, near-constant luminosities of 10^34 cm^{-2}s^{-1} are possible in up to four collision points for a ring of 27km circumference. The achievable luminosity increases with the bending radius, and for 80km circumference, a luminosity of 5 10^34 cm^{-2}s^{-1} in four collision points appears feasible. Beamstrahlung becomes relevant at these high luminosities, leading to a design requirement of large momentum acceptance both in the accelerating system and in the optics. The larger machine could reach the top quark threshold, would yield luminosities per interaction point of 10^36 cm^{-2}s^{-1} at the Z pole (91 GeV) and 2 10^35 cm^{-2}s^{-1} at the W pair production threshold (80 GeV per beam). The energy spread is reduced in the larger ring with respect to what is was at LEP, giving confidence that beam polarization for energy calibration purposes should be available up to the W pair threshold. The capabilities in term of physics performance are outlined.Comment: Submitted to the European Strategy Preparatory Group 01-04-2013 new version as re-submitted to PRSTA

    Experimental Studies of Compensation of Beam-Beam Effects with Tevatron Electron Lenses

    Get PDF
    Applying the space-charge forces of a low-energy electron beam can lead to a significant improvement of the beam-particle lifetime limit arising from the beam-beam interaction in a high-energy collider [1]. In this article we present the results of various beam experiments with electron lenses, novel instruments developed for the beam-beam compensation at the Tevatron, which collides 980-GeV proton and antiproton beams. We study the dependencies of the particle betatron tunes on the electron beam current, energy and position; we explore the effects of electron-beam imperfections and noises; and we quantify the improvements of the high-energy beam intensity and the collider luminosity lifetime obtained by the action of the Tevatron Electron Lenses.Applying the space-charge forces of a low-energy electron beam can lead to a significant improvement of the beam-particle lifetime limit arising from the beam-beam interaction in a high-energy collider [1]. In this article we present the results of various beam experiments with electron lenses, novel instruments developed for the beam-beam compensation at the Tevatron, which collides 980-GeV proton and antiproton beams. We study the dependencies of the particle betatron tunes on the electron beam current, energy and position/ we explore the effects of electron-beam imperfections and noises/ and we quantify the improvements of the high-energy beam intensity and the collider luminosity lifetime obtained by the action of the Tevatron Electron Lenses

    Understanding the Treatment Algorithm of Patients with Metastatic Pancreatic Neuroendocrine Neoplasms: A Single-Institution Retrospective Analysis Comparing Outcomes of Chemotherapy, Molecular Targeted Therapy, and Peptide Receptor Radionuclide Therapy in 255 Patients

    Get PDF
    Background The number of therapeutic options for patients with pancreatic neuroendocrine neoplasms (PNEN) has increased, but the optimal therapeutic algorithm has not been defined due to lack of randomised trials comparing different modalities. Methods We performed a retrospective study in patients with metastatic PNEN treated with ≥1 line of systemic therapy. The relationship between baseline characteristics, treatment type and time to treatment failure (TTF), time to progression (TTP) and overall survival (OS) was analysed using the Kaplan-Meier method. Univariate and multivariate analyses were performed using the Cox proportional hazards model. Results Two hundred and fifty-five patients with metastatic PNEN had 491 evaluable lines of therapy. Independent predictors of TTF included treatment type, Ki-67, tumour grade and chromogranin A. To reduce selection bias, a subgroup of 114 patients with grade 2 (G2) metastatic pancreatic neuroendocrine tumours (PNET) was analysed separately. These patients had received 234 lines of treatment (105 chemotherapy, 82 molecular targeted therapy, and 47 peptide receptor radionuclide therapy [PRRT]). In the G2 cohort, TTF and TTP were superior for PRRT compared with both chemotherapy and molecular targeted therapy. OS in the G2 cohort was also superior for those that had received PRRT compared with those that had not (median 84 vs 56 months; HR 0.55, 95%CI 0.31-0.98, p=0.04). Conclusions This study suggests that PRRT is associated with superior clinical outcomes relative to other systemic therapies for G2 metastatic PNET. Prospective studies are required to confirm these observations

    On the influence of the cosmological constant on gravitational lensing in small systems

    Full text link
    The cosmological constant Lambda affects gravitational lensing phenomena. The contribution of Lambda to the observable angular positions of multiple images and to their amplification and time delay is here computed through a study in the weak deflection limit of the equations of motion in the Schwarzschild-de Sitter metric. Due to Lambda the unresolved images are slightly demagnified, the radius of the Einstein ring decreases and the time delay increases. The effect is however negligible for near lenses. In the case of null cosmological constant, we provide some updated results on lensing by a Schwarzschild black hole.Comment: 8 pages, 1 figure; v2: extended discussion on the lens equation, references added, results unchanged, in press on PR

    The role of the carotenoids, lutein and zeaxanthin, in protecting against age-related macular degeneration: A review based on controversial evidence

    Get PDF
    PURPOSE: A review of the role of the carotenoids, lutein and zeaxanthin, and their function in altering the pathogenesis of age-related macular degeneration (AMD). METHODS: Medline and Embase search. RESULTS: Recent evidence introduces the possibility that lutein and zeaxanthin, carotenoids found in a variety of fruits and vegetables may protect against the common eye disease of macular degeneration. This potential and the lack to slow the progression of macular degeneration, has fueled high public interest in the health benefits of these carotenoids and prompted their inclusion in various supplements. The body of evidence supporting a role in this disease ranges from basic studies in experimental animals to various other clinical and epidemiological studies. Whilst some epidemiological studies suggest a beneficial role for carotenoids in the prevention of AMD, others are found to be unrelated to it. Results of some clinical studies indicate that the risk for AMD is reduced when levels of the carotenoids are elevated in the serum or diet, but this correlation is not observed in other studies. Published data concerning the toxicity of the carotenoids or the optimum dosage of these supplements is lacking. CONCLUSION: An intake of dietary supplied nutrients rich in the carotenoids, lutein and zeaxanthin, appears to be beneficial in protecting retinal tissues, but this is not proven. Until scientifically sound knowledge is available we recommend for patients judged to be at risk for AMD to: alter their diet to more dark green leafy vegetables, wear UV protective lenses and a hat when outdoors. Future investigations on the role of nutrition, light exposure, genetics, and combinations of photodynamic therapy with intravitreal steroid (triamcinolone-acetonide) injections hold potential for future treatment possibilities
    • …
    corecore